Surgery Reconciled Depreciation from 2010 to 2024

SGRY Stock  USD 25.63  0.30  1.16%   
Surgery Partners Reconciled Depreciation yearly trend continues to be fairly stable with very little volatility. Reconciled Depreciation will likely drop to about 97.6 M in 2024. During the period from 2010 to 2024, Surgery Partners Reconciled Depreciation regression line of annual values had r-squared of  0.78 and arithmetic mean of  72,128,598. View All Fundamentals
 
Reconciled Depreciation  
First Reported
2014-09-30
Previous Quarter
31.1 M
Current Value
33.7 M
Quarterly Volatility
10.7 M
 
Yuan Drop
 
Covid
Check Surgery Partners financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Surgery Partners' main balance sheet or income statement drivers, such as Depreciation And Amortization of 79 M, Interest Expense of 151.6 M or Selling General Administrative of 80.8 M, as well as many indicators such as Price To Sales Ratio of 1.52, Dividend Yield of 0.0014 or PTB Ratio of 2.12. Surgery financial statements analysis is a perfect complement when working with Surgery Partners Valuation or Volatility modules.
  
Check out the analysis of Surgery Partners Correlation against competitors.
For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.

Latest Surgery Partners' Reconciled Depreciation Growth Pattern

Below is the plot of the Reconciled Depreciation of Surgery Partners over the last few years. It is Surgery Partners' Reconciled Depreciation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Surgery Partners' overall financial position and show how it may be relating to other accounts over time.
Reconciled Depreciation10 Years Trend
Slightly volatile
   Reconciled Depreciation   
       Timeline  

Surgery Reconciled Depreciation Regression Statistics

Arithmetic Mean72,128,598
Geometric Mean68,373,230
Coefficient Of Variation35.11
Mean Deviation22,172,451
Median51,928,000
Standard Deviation25,321,539
Sample Variance641.2T
Range64.7M
R-Value0.88
Mean Square Error150T
R-Squared0.78
Significance0.000012
Slope5,009,324
Total Sum of Squares8976.5T

Surgery Reconciled Depreciation History

202497.6 M
2023116.6 M
2022114.8 M
202198.8 M
202094.8 M
201976.5 M
201867.4 M

About Surgery Partners Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Surgery Partners income statement, its balance sheet, and the statement of cash flows. Surgery Partners investors use historical funamental indicators, such as Surgery Partners's Reconciled Depreciation, to determine how well the company is positioned to perform in the future. Although Surgery Partners investors may use each financial statement separately, they are all related. The changes in Surgery Partners's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Surgery Partners's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Surgery Partners Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Surgery Partners. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Reconciled Depreciation116.6 M97.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Surgery Stock Analysis

When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.